See what Compass Pathways’ Phase 3 COMP360 TRD data showed, why the stock jumped, and how a discounted offering reshapes the near-term setup.

In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.

The race to fill former Rep. Marjorie Taylor Greene's (R-GA) seat could "cause heartburn for Republicans" if none of their ...

The U.S. Food and Drug Administration issued its first formal guidance on how to design and run clinical trials for psychedelic drugs, a move that directly clears a path for psilocybin, the active ...

Ever wonder what it’s like to drive a streetcar during one of New Orleans’ most chaotic times of year? Go behind the scenes with a driver whose been doing it for more than a decade. “You never know ...

The Dallas Mavericks hit the road short-handed on Friday night, as they kick off the second half of their season with a matchup against Anthony Edwards and the Minnesota Timberwolves. The game is ...

Psilocybin is being studied in controlled trials for depression and PTSD, with some promising early results. But these ...

Kyle Rittenhouse is supporting a politician running to represent Georgia in the seat vacated by Marjorie Taylor Greene.

People taking DMT tended to experience significant relief from their depression for up to three months, the researchers found ...

A Phase IIa clinical trial finds that a single, brief dose of DMT (from ayahuasca) provides rapid and lasting relief for depression.

This fantasy series follows dragon riders in a captivating fantasy series full of political intrigue and romance.